Plain-English translation of NCT07116343 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether , a local numbing medication, can help reduce pain after heart surgery when placed directly into the chest cavity through drainage tubes. After cardiac surgery, patients often experience significant pain from the drainage tubes that surgeons leave in place for a few days. This trial compares the medication to a placebo to see if the treatment helps patients recover more comfortably.
After heart surgery, patients often struggle with pain from the drainage tubes left in the chest, and traditional pain medications like opioids may carry risks. This study explores whether delivering numbing medication directly to the area where the pain originates could be a safer and more effective way to manage this specific type of post-surgery pain.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive heart surgery as planned, and during the operation your surgeon will place drainage tubes in your chest as they normally would. Through these tubes, you will receive either the study medication or a placebo (an inactive substance) to help manage pain during your recovery. Your medical team will monitor your pain levels and recovery over the course of 1 to 3 days while the drainage tubes are in place.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Russia